Telomerase activity and Bcl-2 expression in non-small cell lung cancer

Clinical Cancer Research

Volumn 6, Issue 8, 2000, Pages 2980-2987

  Ohmura, Yasushi ^a   Aoe, Motoi ^a   Andou, Akio ^a   Shimizu, Nobuyoshi ^a  

^a OKAYAMA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53; TELOMERASE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033890250     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Symonds, H., Krall, L., Remington, L., Saenz-Robles, M., Lowe, S., Jacks, T., and Van Dyke, T. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell, 78: 703-711, 1994.
2. Wyllie, A. H. The genetic regulation of apoptosis. Curr. Opin. Genet. Dev., 5: 97-104, 1995.
3. Vaux, D. L., Cory, S., and Adams, J. M. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc immortalized pre-B cells. Nature (Lond.), 335: 440-442, 1988.
4. Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., and Mason, D. Y. bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329: 690-694, 1993.
5. Fontanini, G., Vignati, S., Bigini, D., Mussi, A., Lucchi, M., Angeletti, C. A., Basolo, F., and Bevilacqua, G. Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br. J. Cancer, 71: 1003-1007, 1995.
6. Ohsaki, Y., Toyoshima, E., Fujiuchi, S., Matsui, H., Hirata, S., Miyokawa, N., Kubo, Y., and Kikuchi, K. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time. Clin. Cancer Res., 2: 915-920, 1996.
7. Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., Nakamori, S., and Tateishi, R. bcl-2 oncoprotein in surgically resected non-small cell lung cancer: possibly favorable prognostic factor in association with low incidence of distant metastasis. J. Surg. Oncol., 64: 48-54, 1997.
8. Ishida, H., Irie, K., Itoh, T., Furukawa, T., and Tokunaga, O. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Cancer (Phila.), 80: 1034-1045, 1997.
9. Laudanski, J., Chyczewski, L., Niklinska, W. E., Kretowska, M., Furman, M., Sawicki, B., and Niklinski, J. Expression of bcl-2 protein in non-small cell lung cancer: correlation with clinicopathology and patient survival. Neoplasma (Bratisl.), 46: 25-30, 1999.
10. Dosaka-Akita, H., Katabami, M., Hommura, H., Fujioka, Y., Katoh, H., and Kawakami, Y. Bcl-2 expression in non-small cell lung cancers: higher frequency of expression in squamous cell carcinomas with earlier pT status. Oncology, 56: 259-264, 1999.
11. Anton, R. C., Brown, R. W., Younes, M., Gondo, M. M., Stephenson, M. A., and Cagle, P. T. Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: analysis of 427 cases. Hum. Pathol., 28: 1079-1082, 1997.
12. Greenblatt, M. S., Bennet, W. P., Hollstein, M., and Harris, C. C. Mutation in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54: 4855-4878, 1994.
13. Zakian, V. A. Structure and function of telomeres. Annu. Rev. Genet., 23: 579-604, 1989.
14. de Lange, T. Activation of telomerase in a human tumor. Proc. Natl. Acad. Sci. USA, 91: 2882-2885, 1994.
15. Harley, C. B., and Villeponteau, B. Telomere and telomerase in aging and cancer. Curr. Opin. Genet. Dev., 5: 249-255, 1995.
16. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
17. Mandal, M., and Kumar, R. Bcl-2 modulates telomerase activity. J. Biol. Chem., 272: 14183-14187, 1997.
18. Albanell, J., Lonardo, F., Rusch, V., Engelhardt, M., Langenfeld, J., Han, W., Klimstra, D., Venkatraman, E., Moore, M. A. S., and Dmitrovsky, E. High telomerase activity in primary lung cancers: association with increased cell proliferation rates and advanced pathologic stage. J. Natl. Cancer Inst., 89: 1609-1615, 1997.
19. Marchetti, A., Bertacca, G., Buttitta, F., Chella, A., Quattrocolo, G., Angeletti, C. A., and Bevilacqua, G. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer. Clin. Cancer Res., 5: 2077-2081, 1999.
20. Wu, X., Kemp, B., Amos, C. I., Honn, S. E., Zhang, W., Walsh, G. L., and Spitz, M. R. Association among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer. Br. J. Cancer, 80: 453-457, 1999.
21. Mountain, C. F. Revisions in the international system for staging lung cancer. Chest, 111: 1710-1717, 1997.
22. Mountain, C. F., and Dresler, C. M. Regional lymph node classification for lung cancer staging. Chest, 111: 1718-1723, 1997.
23. Vyberg, M., and Nielsen, S. Dextran polymer conjugate two-step visualization system for immunohistochemistry. Appl. Immunohistochem., 6: 3-10, 1998.
24. Sabattini, E., Bisgaard, K., Ascani, S., Poggi, S., Piccioli, M., Ceccarelli, C., Pieri, F, Fraternali-Orcioni, G., and Pieri, S. A. The EnVision+ system: a new immunohistochemical method for diagnostic and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J. Clin. Pathol., 51: 506-511, 1998.
25. Ohyashiki, J. H., Ohyashiki, K., Sano, T., and Toyama, K. Non-radioisotopic and semi-quantitative procedure for terminal repeat amplification protocol. Jpn. J. Cancer Res., 87: 329-331, 1996.
26. Hollander, M., and Wolfe, D. A. Nonparametric Statistical Methods. New York: Wiley, 1973.
27. Kim, Y. C., Park, K. O., Kern, J. A., Park, C. S., Lim, S. C., Jang, A. S., and Yang, J. B. The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients. Lung Cancer, 22: 181-190, 1998.
28. Quinlan, D. C., Davidson, A. G., Summers, C. L., Warden, H. E., and Doshi, H. M. Accumulation of p53 protein correlates with a poor prognosis in human lung cancer. Cancer Res., 52: 4828-4831, 1992.
29. Fujino, M., Dosaka-Akita, H., Harada, M., Hiroumi, H., Kinoshita, I., Akie, K., and Kawakami, Y. Prognostic significance of p53 and ras p-21 expression in non-small cell lung cancer. Cancer (Phila.), 76: 2457-2463, 1995.
30. McLaren, R., Kuzu, I., Dunnill, M., Harris, A., Lane, D., and Gatter, K. C. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br. J. Cancer, 66: 735-738, 1992.
31. Brambilla, E., Gazzeri, S., Moro, D., de Fromentel, C. C., Gouyer, V., Jacrot, M., and Braambilla, C. Immunohistochemical study of p53 in human lung carcinomas. Am. J. Pathol., 143: 199-210, 1993.
32. Charpin, C., DeVictor, B., Andrac, L., Amabile, J., Bergeret, D., LaVaut, M. N., Allasia, C., and Piana, L. P-53 quantitative immunocytochemical analysis in breast carcinomas. Hum. Pathol., 26: 159-166, 1995.
33. Silvestrini, R., Veneroni, S., Daidone, M. G., Benini, E., Boracchi, P., Mezzetti, M., Di Fronzo, G., Rilke, F., and Veronesi, U. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J. Natl. Cancer Inst., 86: 499-504, 1994.
34. Ritter, J. H., Dresler, C. M., and Wick, M. R. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma. Hum. Pathol., 26: 1227-1232, 1995.
35. Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., and Shay, J. W. Telomerase activity in small-cell and non-small-cell lung cancers. J. Natl. Cancer Inst., 87: 895-902, 1995.
36. Mori, M., Kaji, M., Tezuka, F., and Takahashi, T. Comparative ultrastructural study of atypical adenomatous hyperplasia and adenocarcinoma of the human lung. Ultrastruct. Pathol., 22: 459-466, 1998.
37. Walker, C., Robertson, L., Myskow, M., and Dixon, G. Expression of the BCL-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br. J. Cancer, 72: 164-169, 1995.
38. Yashima, K., Litzky, L. A., Kaiser, L., Roger, T., Lam, S., Wistuba, I. I., Milchrgub, S, Srivastava, S., Piatyszek, M. A., Shay, J. W., and Gazdar, A. F. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res., 57: 2373-2377, 1997.
39. Athanassiadou, P., Dosios, T., Petrakakou, E., Liossi, A., Zerva, C., and Athanassiades, P. p53 and bcl-2 protein expression in non-small-cell lung carcinoma. Diagn. Cytopathol., 19: 255-259, 1998.
40. van Slooten, H. J., Clahsen, P. C., van Dierendonck, J. H., Duval, C., Pallud, C., Mandard, A. M., Delobelle-Deroide, A., van de Velde, C. J. H., and van de Vijver, M. J. Expression of BCL-2 in node-negative breast cancer is associated with various prognostic factors, but does not predict response to one course of perioperative chemotherapy. Br. J. Cancer, 74: 78-85, 1996.
41. Hauge, A., Moorghen, M., Hicks, D., Chapman, M., and Paraskeva, C. BCL-2 expression in human colorectal adenomas and carcinomas. Oncogene, 9: 3367-3370, 1994.
42. Ben-Ezra, J. M., Kornstein, M. J., Grimes, M. M., and Krystal, G. Small cell carcinomas of the lung express the Bcl-2 protein. Am. J. Pathol., 145: 1036-1040, 1994.
43. Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., and Tateishi, R. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer. Anticancer Res., 15: 503-505, 1995.
44. Takayama, K., Ogata, K., Nakanishi, Y., Yatsunami, J., Kawasaki, M., and Hara, N. Bcl-2 expression as a predictor chemosensitivities and survival in small cell lung cancer. Cancer J. Sci. Am., 2: 212-216, 1996.
45. Yan, J. J., Chen, F. F., Tsai, Y. C., and Jin, Y. T. Immunohisto-chemical detection of Bcl-2 protein in small cell lung carcinomas. Oncology, 53: 6-11, 1996.
46. Jiang, S. X., Sato, Y., Kuwao, S., and Kameya, T. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J. Pathol., 177: 135-138, 1995.
47. Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., and Tateishi, R. Bcl-2 oncoprotein expression is increased especially in the portion of small cell carcinoma within the combined type of small cell lung cancer. Tumor Biol., 17: 341-344, 1996.
48. Tsujimoto, Y. Stress-resistance conferred by high level of bcl-2α protein in human B lymphoblastoid cell. Oncogene, 4: 1331-1336, 1989.
49. Sentmen, C. L., Shutter, J. R., Hockenbery, D., Kanagawa, O., and Korsmeyer, S. J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell, 29: 879-888, 1991.
50. Miyashita, T., and Reed, J. C. Bcl-2 gene transfer increases relative resistance of S49.1 and WEH17.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs. Cancer Res., 52: 5407-5411, 1992.
51. Lotem, J., and Sachs, L. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and defective myeloid leukemia cells. Cell Growth Differ., 4: 41-47, 1993.
52. Ishikawa, F. A review article: telomere crisis, the driving force in cancer cell evolution. Biochem. Biophys. Res. Commun., 230: 1-6, 1997.